
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B

The SPIRIT‑HF trial, designed to test spironolactone in heart‑failure patients with preserved or mildly reduced ejection fraction, enrolled only 730 of the planned 1,564 participants and therefore lacked statistical power. Over two years, the composite of cardiovascular death or total heart‑failure hospitalizations occurred at 10.9 per 100 patient‑years with spironolactone versus 8.2 with placebo, a non‑significant difference. High rates of drug discontinuation—driven by side effects and pandemic‑related challenges—further limited interpretability. Researchers plan to rely on the larger, ongoing SPIRRIT registry trial for a definitive answer.

The United States sees roughly 200,000 lawsuits annually, with 66,000‑85,000 classified as medical malpractice claims. Only 22,000‑44,000 of those result in plaintiff settlements or verdicts, while about two‑thirds are dismissed or favor defendants. The article argues that many suits stem...

Rocket Pharmaceuticals received FDA approval on March 27 for KRESLADI, its first marketed product and the first gene therapy for a rare pediatric disorder. The clearance also awarded the company a Rare Pediatric Disease Priority Review Voucher, which can be...
Researchers at UT Southwestern reported encouraging early results from a deep brain stimulation (DBS) trial targeting treatment‑resistant depression, a condition affecting roughly 30% of patients who fail conventional therapies. The study, part of the national TRANSCEND trial, suggests that electrical...
A randomized trial delivering DASH‑aligned groceries to Black adults with hypertension lowered systolic blood pressure by an average of 7 mm Hg and LDL cholesterol by 7 mg/dL after three months, outperforming a control group that received only a stipend and pamphlet. Researchers...
A Cleveland Clinic secondary analysis of a 13,000‑patient trial shows tirzepatide lowers the combined risk of heart attack, stroke, heart failure, kidney failure and death by 16% versus dulaglutide. The findings, presented at the ACC meeting, give longevity‑focused biohackers new...

The modern health care system cannot be fixed with more academic jargon or sterile clinical lectures. We have enough data. What we lack are the raw human stories behind the stethoscope. For too long, the diverse voices that actually make up our...

Physicians in primary care are forced into 10‑minute visits, seeing four to six patients per hour, which compresses complex assessments into brief transactions. The time crunch pushes clinicians toward early imaging, quick referrals, and reliance on standardized guidelines rather than...
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-951246244-aafb86a3556145b8b2ad04415d62b09b.jpg)
Antidepressant prescriptions remain among the most common in the United States, with selective serotonin reuptake inhibitors (SSRIs) accounting for roughly 70 % of all treatments. Recent surveys show that more than 14 % of Americans aged 12 and older used an antidepressant...

Superbug resistance is accelerating worldwide, with the World Health Organization warning that one in six infection‑causing microbes now defy antibiotics. Between 2018 and 2023, resistance rose in over 40% of monitored pathogen‑drug pairings, averaging a 5‑15% annual increase. The WHO...

The essay argues that health‑tech firms that avoid HIPAA’s Business Associate Agreement (BAA) can scale like consumer software, unlocking venture‑scale growth. OpenEvidence exemplifies this model, leaping from zero to $50 million ARR, then $150 million ARR, and a $12 billion valuation in about...

Genetic interleukin-6 receptor blockade, chronic disease risk, and longevity: results from the women’s health initiative Lay Summary: "The role of interleukin-6 receptor (IL6R) blockade in reducing chronic-disease risk and improving longevity is uncertain. In a study of 38 807 postmenopausal women followed for...
Jefferies has initiated coverage of Vor Biopharma with a buy rating and a $50 price target, far above the current $14.48 share price. The company recently pivoted to autoimmune diseases, licensing telitacicept for lupus, rheumatoid arthritis, and myasthenia gravis, and...
London Health Sciences Centre (LHSC) opened an Indigenous healing space called ‘ReconciliAction’ within its mental‑health department on March 27, 2026. Funded by the hospital’s budget and Indigenous‑partner grants, the room offers a medicine circle, local art and ventilation for smudging...
The FDA has released a proposed rule to broaden the definition of dietary ingredients to include non‑food substances such as peptides and certain probiotics. The move, driven by a petition from the Natural Products Association, could unlock a wave of...

Melbourne fertility clinics are increasingly turning to egg donation to help couples overcome age‑related, genetic, or medical infertility. Donor eggs, typically sourced from women aged 21‑34, are screened, fertilised and transferred after a quarantine period, markedly improving pregnancy odds. Clinics...

Vitamin K deficiency bleeding is a preventable condition. These are real stories from real pediatricians. The risk is 1/60 of bleeding in the first few months o

Merck announced that its experimental drug Winrevair will move into a pivotal Phase 3 trial for a rare form of heart failure, focusing on the lowest dose tested in Phase 2. The Phase 2 data showed a "pretty profound" efficacy signal at that...
The mother of an angiosarcoma patient reached out this weekend to see if I could help her daughter get a second opinion at Dana-Farber after it was rejected by her insurer. I'll do what I can. Dana-Farber has made a...
Nektar Therapeutics presented Phase 2b data at the 2026 American Academy of Dermatology meeting showing statistically significant EASI improvements in 393 atopic dermatitis patients and a 28.2% mean SALT reduction in alopecia areata. The results position rezpegaldesleukin as the first IL‑2‑based...

Delirium affects up to half of older hospitalized patients and is often accepted as inevitable, but thiamine deficiency is emerging as a hidden, reversible driver. The deficiency is common in critically ill and dialysis patients, where rapid loss of water‑soluble...
Researchers at Yale School of Medicine have devised a blood test that reads epigenetic methylation patterns in white‑blood cells to predict which endometriosis patients will respond to progesterone‑based birth control. The study examined 31 women, identified over 1,400 differentially methylated...
In ICU ₹50,000/day only for medicine cost? The viral post on 'X' went viral, which raises concerns about the Indian healthcare system. A man shared his friend's experience. His friend's grandmother was admitted to the ICU in a private hospital. She was admitted in...
Long-term effect of discontinuing anticholinesterase treatment on cognitive decline and mortality in Alzheimer's disease in France: a quasi-experiment and target trial emulation study https://t.co/YUcSc7w9HG
At the American Academy of Dermatology 2026 meeting, researchers presented TRACE, a real‑world study of tralokinumab in atopic dermatitis. The trial enrolled over 800 patients, with roughly 16% representing skin‑of‑color individuals (Fitzpatrick types 4‑6). After 12 months, 80% of this subgroup achieved...
The primary “failure” was that Covid measures lasted until the Summer of 2022, especially as they were enforced on children and public school & daycare Well after adults (with a choice) had stopped complying, little kids were masked for 8 hours/day...
The microtubule nexus linking amyloid beta and tau: A simple and unifying theory for the underlying cause of Alzheimer's disease https://t.co/dRJUJku6yu

A community health worker‑led, barbershop‑based program aimed at preventing hypertension in Black men was evaluated in a cluster‑randomized trial across 22 barbershops involving 430 participants. The primary endpoint—change in systolic blood pressure over 12 months—showed no significant reduction in either...

Chronic rapamycin treatment attenuates age-related motor deficits in sex-dependent manner in UM-HET3 mice 👉"Our results are consistent with the idea that rapamycin’s beneficial effects are mediated, at least in part, by reducing oxidative stress and ER stress-mediated apoptosis... https://t.co/b8EZwrDTXP

Heart-Brain Axis Atrial fibrillation leads to reduced brain glymphatic flow, decreased washout of waste metabolites. https://t.co/2PNjoDl4Om Today #ACC26 @JAMACardio Serum Neurofilament (sNfl), a marker for brain cell injury, is associated with adverse CV events and mortality in patients with atrial fibrillation https://t.co/fWNg8zks0C
The University of Chicago Medicine opened a Level 1 trauma center in May 2018, cutting average transport time for gunshot victims by roughly ten minutes and distance by 3.4 miles. An analysis of more than 45,000 Chicago shootings from 2010‑2024 showed a 3.9%...

The list of conditions for which GLP-1 drugs provide benefit independent of weight loss keeps growing. Add psoriatic arthritis #AAD26 @AADskin https://t.co/kJej6osXTS
A new global review highlights stark differences in how nations regulate polygenic embryo testing, a rapidly expanding extension of pre‑implantation genetic testing (PGT). While the United States has permitted commercial polygenic screening since 2019, many European countries limit testing to...

A recent International Myeloma Society summit introduced a formal definition of "cure" for multiple myeloma, sparking debate among oncologists, patients, and advocates. Advances such as CAR‑T cell therapy have pushed five‑year survival rates to 62%, prompting some clinicians to label...

A statistician highlights the difficulty of judging scientific evidence, contrasting p‑values and e‑values that can lead to opposite conclusions about the same data. He argues that thresholds for significance are subjective, turning gray‑area findings into binary claims. The piece warns...
Topical immunotherapy using contact allergens such as diphenylcyclopropenone (DPCP) or squaric acid dibutyl ester (SADBE) remains an effective, affordable option for alopecia areata, even as high‑cost JAK inhibitors dominate headlines. A recent Frontiers in Medicine case series of five chronic...
Mexico's federal government announced a national mental‑health initiative for secondary and upper‑secondary students, expanding a pilot program after a 15‑year‑old opened fire at a Michoacan high school. The plan focuses on teacher training, school‑based psychologists and family guidance to curb...
The USDA and HHS released the 2025‑2030 Dietary Guidelines, upping recommended protein to 1.2‑1.6 g per kilogram body weight and emphasizing whole, nutrient‑dense foods. Nutrition experts praised the microbiome focus but warned that fiber, whole‑grain and plant‑based milk guidance remain weak.
Brooklyn resident Luyba Caloras, 35, was diagnosed with severe postpartum preeclampsia and heart failure days after delivering her son at NYU Langone Health. Her treatment in the hospital’s Cardio‑Obstetrics Program underscores critical gaps in postpartum cardiac monitoring and has reignited...
A new Karolinska Institute analysis of more than one million health records shows diagnoses of paternal depression surge by over 30% twelve months after a child’s birth. The finding overturns the long‑standing belief that the highest risk occurs in the...
Eli Lilly’s once‑daily oral GLP‑1 agonist orforglipron outperformed oral semaglutide (Wegovy) in a 52‑week Phase 3 trial of 1,698 adults, delivering 73.6% greater relative weight loss and a three‑fold higher rate of A1c normalization. The data, published in The Lancet, could reshape...

Healthcare leaders face mounting financial strain from workforce shortages, Medicaid cuts and the One Big Beautiful Bill Act, which could generate $200 billion in uncompensated care by 2034. While clinical costs dominate attention, non‑clinical expenses such as IT, facilities and corporate...
Researchers have engineered microscopic DNA nanorobots that can recognize and bind to COVID‑19 viral particles. The breakthrough, described in a recent SmartBot feature, points to a future where nanotech diagnostics and therapeutics operate inside the human body with unprecedented precision.
Johnson & Johnson unveiled 52‑week Phase 3 data for ICOTYDE™ (icotrokinra), revealing PASI 100 clearance rates of 41‑49% in adults and 57% in adolescents, with no new safety signals. The results position the oral peptide as a possible disease‑modifying first‑line option for...
Researchers report that Richter transformation (RT) can be identified years before clinical onset in chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) patients through multi‑omics profiling of tiny subclones. Current anthracycline‑based chemoimmunotherapy delivers median overall survival under one year,...

Two leading medical journal editors—Marcia Angell of the New England Journal of Medicine and Richard Horton of The Lancet—have publicly warned that a large portion of contemporary clinical research is unreliable. Angell argued in 2009 that clinicians can no longer...
The article breaks down how patients can cut prescription costs amid a growing maze of discount options, from brand‑name sites like TrumpRx to coupon‑heavy platforms such as GoodRx and Cost Plus Drugs. It highlights the stark price gap between brand drugs—e.g., Protonix...
A new JAMA Internal Medicine study examined over 386,000 adults to assess whether caffeine intake influences arrhythmia risk. After adjusting for genetic differences in caffeine metabolism, researchers found no evidence that higher coffee consumption raises the likelihood of irregular heartbeats....
Emerging diabetes therapies are reshaping treatment of metabolic dysfunction‑associated steatotic liver disease (MASLD), especially its severe form MASH. GLP‑1 receptor agonists such as semaglutide and dual‑action agents like tirzepatide have shown significant liver‑fat reduction and histologic improvement. SGLT2 inhibitors and...

Direct-to-consumer (DTC) pharmaceutical advertising in the United States now commands $6‑8 billion in annual TV spend, propelling antipsychotics and biologics into mainstream consumer consciousness. Companies such as Eli Lilly and AbbVie have poured $30 million‑$24 million per month into campaigns for drugs like Rexulti...